Elevated blood-based p-tau217 levels predict up to 38% risk of cognitive impairment over 10 years in unimpaired older adults.
- 6 cites
Rebuilt
Elevated blood-based p-tau217 levels predict up to 38% risk of cognitive impairment over 10 years in unimpaired older adults.
A single Centiloid cutoff of 18 best distinguishes amyloid positivity in PET scans across diverse studies, with a high predictive value for visual reads.
Blood biomarkers and digital measures together can improve Alzheimer’s disease care beyond diagnostic accuracy alone.
Newest first · last 60 days
Mendelian randomization and multiomics analyses identified 19 druggable targets for Alzheimer's disease, including protective variants in EPHX2, in individuals of European and African ancestry.
Hepatic expression of APOE3 Christchurch reduces amyloid-β burden and AD pathologies in APOE4-expressing APP/PS1 mice.
A single Centiloid cutoff of 18 best distinguishes amyloid positivity in PET scans across diverse studies, with a high predictive value for visual reads.
APOE-stratified GWAS identified new genetic signals for Alzheimer's disease risk, including DDHD1, with effects specific to APOE ε4 and ε2 carrier status.
Functional connectivity changes linked to aging and Alzheimer's disease are aligned with distinct hierarchical brain communication axes, with AD associated with the sensory-association axis and aging with the representation-executive axis.
DeepFS achieves 89.45% accuracy and 0.9647 AUC in diagnosing Alzheimer's disease from brain tissue transcriptomic data.
Journals this month
Topics moving, week to 22 Oct 2026